Today's Top 5
5. Immunotherapy for a Rare Cancer
Some people with a rare cancer called advanced alveolar soft part sarcoma may benefit from a type of #immunotherapy: https://t.co/j7C1wAAZi9 pic.twitter.com/eTqMkHPUjC
— National Cancer Institute (@theNCI) February 14, 2019
4. “Watch and Wait” Increasing for Prostate Cancer
Many more men deciding to wait and watch, instead of rush to treat prostate cancer. Looks the harm/benefit evidence is starting to have an effect. https://t.co/TghaUmJX5G @JAMA_current
— Andrew Holtz (@HoltzReport) February 11, 2019
3. International Childhood Cancer Day
Today is International Childhood Cancer Day. Dana-Farber/Boston Children’s Global Health Initiative is collaborating with partners worldwide to improve outcomes for children no matter where they live. pic.twitter.com/vuRQ1H7Abl
— Dana-Farber (@DanaFarber) February 15, 2019
2. Biases in Cancer Care Decisions
#JCOCCI review looks at how cancer patient treatment choices are subconsciously influenced by known & unknown biases https://t.co/MrjzSSgWZ2 pic.twitter.com/VSSvFGphIQ
— J Clinical Oncology (@JCO_ASCO) February 18, 2019
1. FDA Approves Treatment for Melanoma
.@US_FDA approves #Keytruda for adjuvant treatment of #melanoma @Merck https://t.co/zyyJ9nXzve pic.twitter.com/gm78ymWRlw
— HemOnc Today (@HemOncToday) February 19, 2019